Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002512972 | SCV003445791 | pathogenic | Hereditary factor IX deficiency disease; Thrombophilia, X-linked, due to factor 9 defect | 2022-04-21 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 411 of the F9 protein (p.Ser411Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hemophilia B (PMID: 1346975, 29296726, 32875744). This variant is also known as p.Ser365Gly. ClinVar contains an entry for this variant (Variation ID: 10650). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt F9 protein function. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000011396 | SCV000031628 | pathogenic | Hereditary factor IX deficiency disease | 1992-03-01 | no assertion criteria provided | literature only |